CIK 0000882796
- Large accelerated filer
BIOCRYST PHARMACEUTICALS INC
Sign in to watch- Ticker
- BCRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 621413174
- Phone
- +1 919-859-1302
- Business address
- 4505 EMPEROR BOULEVARD, SUITE 200, DURHAM, NC, 27703
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-05-23 | Cohen Fred E Director | Grant or award · Automatic Stock Option Grant | +30,000 | 30,000 | ||
| 2016-05-23 | ABERCROMBIE GEORGE B Director | Grant or award · Automatic Stock Option Grant | +30,000 | 30,000 | ||
| 2016-03-01 | Barnes Alane P VP, General Counsel & Corp Sec | Shares withheld for taxes | −687 | $2.13 | $1K | 85,416 |
| 2016-03-01 | Babu Yarlagadda S Senior VP - Drug Discovery | Shares withheld for taxes | −906 | $2.13 | $2K | 141,428 |
| 2016-03-01 | Sheridan William P Senior VP - CMO | Shares withheld for taxes | −799 | $2.13 | $2K | 90,052 |
| 2016-03-01 | STAAB THOMAS R II Senior Vice President and CFO | Shares withheld for taxes | −465 | $2.13 | $990 | 144,628 |
| 2016-03-01 | Stonehouse Jon P President & CEO | Shares withheld for taxes | −2,761 | $2.13 | $6K | 664,585 |
| 2016-02-29 | SANDERS CHARLES A Director | Grant or award | +4,396 | $1.99 | $9K | 12,971 |
| 2016-02-29 | Hutson Nancy J Director | Grant or award | +4,396 | $1.99 | $9K | 21,862 |
| 2016-02-29 | Cohen Fred E Director | Grant or award | +4,396 | $1.99 | $9K | 109,065 |
| 2016-02-05 | BAKER BROS. ADVISORS LP 10% owner | Purchase | +45,000 | $6.33 | $285K | 12,894,240 |
| 2016-02-04 | BAKER BROS. ADVISORS LP 10% owner | Purchase | +24,800 | $6.65 | $165K | 12,849,240 |
| 2016-02-03 | BAKER BROS. ADVISORS LP 10% owner | Purchase | +91,187 | $6.29 | $573K | 12,824,440 |
| 2016-02-02 | BAKER BROS. ADVISORS LP 10% owner | Purchase | +91,728 | $6.52 | $598K | 12,733,253 |
| 2016-01-29 | Barnes Alane P VP, General Counsel & Corp Sec | Exercise or conversion | +19,368 | $1.42 | $28K | 85,057 |
| 2016-01-29 | Barnes Alane P VP, General Counsel & Corp Sec | Exercise or conversion · Emp. Stock Option (Right to Buy) | −19,368 | 20,632 | ||
| 2016-01-28 | BAKER BROS. ADVISORS LP 10% owner | Purchase | +25,000 | $6.88 | $172K | 12,641,525 |
| 2016-01-27 | BAKER BROS. ADVISORS LP 10% owner | Purchase | +63,345 | $6.98 | $442K | 12,616,525 |
| 2016-01-26 | Powell Lynne Senior VP - CCO | Shares withheld for taxes | −3,850 | $7.29 | $28K | 8,605 |
| 2016-01-22 | BAKER BROS. ADVISORS LP 10% owner | Purchase | +3,200 | $7.00 | $22K | 12,553,180 |
Page 44 of 45 · 882 trades